Mayo Clinic Secures ARPA-H Award to Build a Living Pharmacy Within the Body for Inflammatory Disease
October 03, 2024
October 03, 2024
ROCHESTER, Minnesota, Oct. 3 -- The Mayo Clinic issued the following news release:
Mayo Clinic is the prime site for an ARPA-H award to develop an implantable device that acts as a living pharmacy, triggering a "cell factory" in the body to treat inflammatory disease. ARPA-H, short for Advanced Research Projects Agency for Health, is an agency within the Department of Health and Human Services. It supports research for potentially transformative biomedical and health break . . .
Mayo Clinic is the prime site for an ARPA-H award to develop an implantable device that acts as a living pharmacy, triggering a "cell factory" in the body to treat inflammatory disease. ARPA-H, short for Advanced Research Projects Agency for Health, is an agency within the Department of Health and Human Services. It supports research for potentially transformative biomedical and health break . . .